On February 19, HHS OIG released a final rule that removes safe harbor protection for drug price reductions provided to Part D plan sponsors. The final rule also creates new safe harbors for certain point-of-sale drug price reductions under Part D and Medicaid managed care, and for the fixed fees that manufacturers pay PBMs for certain services. The final rule is effective on January 1, 2023.